Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.4750 (-1.6%) ($6.4750 - $6.4750) on Mon. Nov. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.66% (three month average) | RSI | 27 | Latest Price | $6.4750(-1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.9% a day on average for past five trading days. | Weekly Trend | IOVA declines -10.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(33%) IWC(30%) IWO(27%) IWM(24%) IBUY(23%) | Factors Impacting IOVA price | IOVA will decline at least -2.33% in a week (0% probabilities). UNG(-14%) VXX(-8%) VFMO(-6%) XLU(-5%) XLV(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.33% (StdDev 4.66%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-14.23(-319.77%) | Resistance Level | $8.35 | 5 Day Moving Average | $7(-7.5%) | 10 Day Moving Average | $7.58(-14.58%) | 20 Day Moving Average | $8.35(-22.46%) | To recent high | -45.5% | To recent low | 0% | Market Cap | $948m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |